STIMULATORY EFFECT OF A SPECIFIC SUBSTANCE-P ANTAGONIST (RPR-100893) OF THE HUMAN NK1 RECEPTOR ON THE ESTRADIOL-INDUCED LH AND FSH SURGES IN THE OVARIECTOMIZED CYNOMOLGUS MONKEY
B. Kerdelhue et al., STIMULATORY EFFECT OF A SPECIFIC SUBSTANCE-P ANTAGONIST (RPR-100893) OF THE HUMAN NK1 RECEPTOR ON THE ESTRADIOL-INDUCED LH AND FSH SURGES IN THE OVARIECTOMIZED CYNOMOLGUS MONKEY, Journal of neuroscience research, 50(1), 1997, pp. 94-103
Utilizing a human NK1 receptor antagonist (RPR 100893), the present in
vivo study was designed to test the hypothesis that endogenous substa
nce P (SP) modulates the action of 17 beta-estradiol in inducing lutei
nizing hormone (LH) and follicle stimulating hormone (FSH) surges in o
variectomized cynomolgus monkey. Plasma concentrations of LH and FSH a
s well as NK1 receptor antagonist and SP were measured during the deve
lopment of the negative and positive feedback phases which follow a si
ngle administration of estradiol benzoate (50 mu g/kg) to long-term ov
ariectomized monkeys. Daily administration by gastric intubation of 1
mg/kg or 10 mg/kg of the NK1 receptor antagonist (RPR 100893) leads to
detectable levels of the antagonist in the blood of treated animals f
or at least 6 hr after its administration. These levels are in agreeme
nt with the experimentally determined IC50 value of the antagonist. Th
e most striking finding of this study is that LH and FSH releases are
enhanced during the descending arm of the estradiol benzoate-induced L
H and FSH surges, which suggests that endogenous SP normally has an in
hibitory role during this time. The enhancement of LH release is appro
ximately 50%, regardless of the amount of the NK1 antagonist used. How
ever, the enhanced FSH release is more important. Furthermore, blockad
e of the NK1 receptor with the smaller dose of the antagonist leads to
a small, but significant, increase in plasma levels off SP, indicatin
g that blockade of SP receptors leads to an increased release of SP. C
ollectively, these results further substantiate the link which exists
between the ovarian steroid 17 beta-estradiol and SP systems. Also, fo
r the first time, these results demonstrate an inhibitory involvement
of the human NK1 receptor in the 17 beta-estradiol-induced pseudoovula
tory gonadotropin surges in the ovariectomized monkey. (C) 1997 Wiley-
Liss, Inc.